TY - JOUR
KW - algorithm
KW - diagnosis
KW - electronic health record
KW - hypereosinophilic syndrome
KW - rare disease
AU - G. Requena
AU - S. Joksaite
AU - N. Galwey
AU - R. Jakes
AD - Epidemiology, Value Evidence and Outcomes, Global Research & Development, GSK, Brentford, Middlesex, UK.
Real-World Analytics, Value Evidence and Outcomes, Global Research & Development, GSK, Brentford, Middlesex, UK.
Real World Analytics, Epidemiology, GSK, Stevenage, UK.
AN - 37309054
BT - Pharmacoepidemiol Drug Saf
DO - 10.1002/pds.5655
DP - NLM
ET - 2023/06/13
LA - eng
N1 - 1099-1557
Requena, Gema
Orcid: 0000-0002-1889-6656
Joksaite, Sandra
Galwey, Nicholas
Jakes, Rupert W
Gsk (id: 213879)/
Journal Article
England
Pharmacoepidemiol Drug Saf. 2023 Jun 12. doi: 10.1002/pds.5655.
PY - 2023
SN - 1053-8569
T2 - Pharmacoepidemiol Drug Saf
TI - An algorithm-based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example
ER -